The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
McKinley EC, Bittner VA, Brown TM, Chen L, Exter J, Farkouh ME, Huang L, Jackson EA, Levitan EB, Orroth KK, Reading SR, Rosenson RS, Safford MM, Woodward M, Muntner P, Colantonio LD.
McKinley EC, et al. Among authors: huang l.
Cardiovasc Drugs Ther. 2023 Feb;37(1):107-116. doi: 10.1007/s10557-021-07268-x. Epub 2021 Oct 2.
Cardiovasc Drugs Ther. 2023.
PMID: 34599698